Have you ever thought why none of the vaccines developed for malaria till date has protected against the disease for long? The scientists at QIMR Berghofer Medical Research Institute believe they have found the answer for this.
The discovery potentially paves way for more effective vaccines down the track.
Malaria is caused by parasites that are spread by mosquitoes.
Researchers have been trying to develop a successful vaccine for decades. However, even the most trialled vaccine remained effective even four years after immunisation in a small proportion of people.
Most of the vaccines that have been worked on have aimed to generate antibodies against the parasites.
Dr. Michelle Wykes, the head of the Molecular Immunology Laboratory, along with Joshua Horne-Debets and Deshapriya Karunarathne, found that activating immune cells known as CD8+ T cells was crucial in protecting mice against malaria in the longer term.
"This is the first time there has been evidence to show these immune cells are crucial for protecting against blood stage malaria - which is when symptoms start to show - in the long term. In other words, we've found that antibodies on their own aren't enough to maintain protection against malaria," said Dr. Wykes.
The World Health Organisation (WHO) estimates that malaria caused the deaths of 4,38,000 people and infected 214 million people worldwide in 2015.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)